Ofatumumab

Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes.
Read more
€0.00 (tax incl.)
Reference:
HY-P9961
Product Details
HY-P9961

Data sheet

Size
Multiple sizes
Reactivity
CD20
Application
Cancer-programmed cell death
CAS
679818-59-8

Menu

Settings